Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Diabetic Nephropathy
NCT03664414Phase 4Unknown
- Start
- Mar 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic nephropathy (DN) comparing Pentoxifylline Group with Placebo Group (2 arms). Primary endpoint: Change in the glomerular filtration rate at 24 months. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03664414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664414.